# Efficacy Study in Lumbosacral Radiculopathy

> **NCT01110057** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 142 (actual)

## Conditions studied

- Pain, Neuropathic

## Interventions

- **DRUG:** Placebo
- **DRUG:** GS856553

## Key facts

- **NCT ID:** NCT01110057
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-07
- **Primary completion:** 2010-08-23
- **Final completion:** 2010-08-23
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110057, "Efficacy Study in Lumbosacral Radiculopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01110057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*